Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for Myocardial Protection in Aortic Valve Replacement
NCT00944385Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jun 2009
- Primary completion
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of ulinastatin in aortic valve disease (AVD) (2 arms), sponsored by Yonsei University. Started Jun 2009; status: completed.
02
Drugs
ulinastatin
03
Conditions
aortic valve disease (AVD)
Beyond the preview
Go deeper on NCT00944385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944385.